As of 2024-12-15, the EV/EBITDA ratio of AtriCure Inc (ATRC) is -172.98. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. AtriCure's latest enterprise value is 1,476.60 mil USD. AtriCure's TTM EBITDA according to its financial statements is -8.54 mil USD. Dividing these 2 quantities gives us the above AtriCure EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 14.6x - 16.7x | 16.2x |
| Forward P/E multiples | 17.6x - 27.5x | 20.2x |
| Fair Price | (1.70) - (1.55) | (1.81) |
| Upside | -105.4% - -104.9% | -105.7% |
| Date | EV/EBITDA |
| 2024-12-13 | -172.98 |
| 2024-12-12 | -179.38 |
| 2024-12-11 | -182.35 |
| 2024-12-10 | -186.18 |
| 2024-12-09 | -185.95 |
| 2024-12-06 | -187.72 |
| 2024-12-05 | -186.92 |
| 2024-12-04 | -199.48 |
| 2024-12-03 | -198.40 |
| 2024-12-02 | -203.77 |
| 2024-11-29 | -198.63 |
| 2024-11-27 | -198.68 |
| 2024-11-26 | -196.51 |
| 2024-11-25 | -197.77 |
| 2024-11-22 | -196.20 |
| 2024-11-21 | -195.89 |
| 2024-11-20 | -197.89 |
| 2024-11-19 | -199.66 |
| 2024-11-18 | -190.40 |
| 2024-11-15 | -192.17 |
| 2024-11-14 | -193.77 |
| 2024-11-13 | -198.86 |
| 2024-11-12 | -201.31 |
| 2024-11-11 | -210.28 |
| 2024-11-08 | -206.00 |
| 2024-11-07 | -205.48 |
| 2024-11-06 | -206.97 |
| 2024-11-05 | -194.69 |
| 2024-11-04 | -184.35 |
| 2024-11-01 | -183.49 |
| 2024-10-31 | -181.61 |
| 2024-10-30 | -191.03 |
| 2024-10-29 | -160.19 |
| 2024-10-28 | -156.31 |
| 2024-10-25 | -151.63 |
| 2024-10-24 | -155.91 |
| 2024-10-23 | -156.88 |
| 2024-10-22 | -155.62 |
| 2024-10-21 | -155.11 |
| 2024-10-18 | -156.54 |
| 2024-10-17 | -155.28 |
| 2024-10-16 | -158.65 |
| 2024-10-15 | -155.51 |
| 2024-10-14 | -149.74 |
| 2024-10-11 | -151.11 |
| 2024-10-10 | -146.60 |
| 2024-10-09 | -146.43 |
| 2024-10-08 | -148.14 |
| 2024-10-07 | -146.71 |
| 2024-10-04 | -149.91 |